Aligos Therapeutics Inc Stock Performance
as on October 24, 2025 at 1:29 am IST
Day's Low
Day's High
$9.25$10.3
2.22%
Downside
8.88%
Upside
52 Week's Low
52 Week's High
$3.76$46.860.25%
Downside
394.71%
Upside
Aligos Therapeutics Inc share price movements today
- Previous Close
- $9.84
- Open
- $9.95
- Volume
- 205.7K
- Day's Low - High
- $9.25 - $10.3
- 52 Week Low - High
- $3.76 - $46.8
Aligos Therapeutics Inc Historical Returns
- 1 Month Return
- -4 %
- 3 Month Return
- + 6.03 %
- 1 Year Return
- + 36.48 %
- 3 Year Return
- -62.15 %
- 5 Year Return
- -97.39 %
Aligos Therapeutics Inc Stock Fundamentals & Key Indicators
Check Aligos Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$69.7M
EPS (TTM)
-7.88
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-13.35
Industry PE ratio
-2.8126038781163434
PEG Ratio
0EBITDA
-77.6M
Revenue (TTM)
3.2M
Profit Margin
0.00%
Return On Equity TTM
-87.74%
Aligos Therapeutics Inc Stock Valuation
Track how Aligos Therapeutics Inc P/E has moved over time to understand its valuation trends.
Aligos Therapeutics Inc in the last 5 years
Lowest (-116.34x)
September 30, 2021
Today (-13.35x)
October 23, 2025
Industry (-2.81x)
October 23, 2025
Highest (-0.30x)
June 30, 2025
Today’s Price to Earnings Ratio: -13.35x
Aligos Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aligos Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $69.7M | -97.39% | -13.35 | 0.00% | |
| BUY | $63.1B | 252.62% | -505.15 | -12.96% | |
| NA | $35.3B | NA | NA | -3.89% | |
| BUY | $109.3B | 101.55% | 30.36 | 31.86% | |
| BUY | $61.3B | 0.85% | 14.6 | 31.37% |
Stock Returns calculator for Aligos Therapeutics Inc Stock including INR - Dollar returns
The Aligos Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aligos Therapeutics Inc investment value today
Current value as on today
₹1,35,859
Returns
₹35,859
(+35.86%)
Returns from Aligos Therapeutics Inc Stock
₹31,207 (+31.21%)
Dollar Returns*
₹4,653 (+4.65%)
Analyst Recommendation on Aligos Therapeutics Inc Stock
Based on 8 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Aligos Therapeutics Inc. Average target price of $80.25
Aligos Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Aligos Therapeutics Inc.
What analysts predicted
88.21%UPSIDE
Target Price
$80.25
Current Price
$9.46
Analyzed by
8 Analysts
Target
$80.25
Aligos Therapeutics Inc target price $80.25, a slight upside of 88.21% compared to current price of $9.46. According to 8 analysts rating.
Aligos Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Aligos Therapeutics Inc Stock has increased by 113% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:113% versus previous 30 day period
Aligos Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Aligos Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Aligos Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Aligos Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Aligos Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 311.0K → 965.0K (in $), with an average increase of 67.8% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.7% return, outperforming this stock by 21.2%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 133.8% return, outperforming this stock by 196.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 43.08M → -15.86M (in $), with an average decrease of 136.8% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, ALGS stock has moved down by -6.4%
About Aligos Therapeutics Inc
| Organisation | Aligos Therapeutics Inc |
| Headquarters | One Corporate Drive, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Dr. Lawrence M. Blatt MBA, Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Aligos Therapeutics Inc
Name | Title |
|---|---|
Dr. Hardean E. Achneck M.D. | Executive VP & Chief Medical Officer |
Dr. Kieron Wesson Ph.D. | Vice President & Head of Chemistry Manufacturing Controls |
Ms. Lesley Ann Calhoun CPA | Executive VP, CFO & COO |
Dr. Julian A. Symons DPHIL | Executive VP & Chief Scientific Officer |
Ms. Laura Kavanaugh | VP & Head of Legal |
Dr. Sushmita M. Chanda DABT, Ph.D. | Executive Vice President & Chief Development Officer |
Dr. David B. Smith Ph.D. | Executive VP & Head of Chemical Operations |
Dr. Lawrence M. Blatt MBA, Ph.D. | CEO, President & Chairman of the Board |
Ms. Kristina Engeseth M.B.A. | Senior VP and Head of People & Culture |
Dr. Tse-I Lin Ph.D. | Senior VP of Early Compound Development & Belgian Site Head |
FAQs
What is Aligos Therapeutics Inc share price today?
Aligos Therapeutics Inc share price today is $9.46 as on at the close of the market. Aligos Therapeutics Inc share today touched a day high of $10.3 and a low of $9.25.
What is the 52 week high and 52 week low for Aligos Therapeutics Inc share?
Aligos Therapeutics Inc share touched a 52 week high of $46.8 on and a 52 week low of $3.76 on . Aligos Therapeutics Inc stock price today i.e. is closed at $9.46,which is 79.79% down from its 52 week high and 151.60% up from its 52 week low.
What is Aligos Therapeutics Inc's market capitalisation today?
Aligos Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Aligos Therapeutics Inc Stock (ALGS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aligos Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aligos Therapeutics Inc Shares that will get you 0.1586 shares as per Aligos Therapeutics Inc share price of $9.46 per share as on October 24, 2025 at 1:29 am IST.
What is the minimum amount required to buy Aligos Therapeutics Inc Stock (ALGS) from India?
Indian investors can start investing in Aligos Therapeutics Inc (ALGS) shares with as little as ₹87.835 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Aligos Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aligos Therapeutics Inc share’s latest price of $9.46 as on October 24, 2025 at 1:29 am IST, you will get 1.0571 shares of Aligos Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Aligos Therapeutics Inc has given to Indian investors in the last 5 years?
Aligos Therapeutics Inc stock has given -97.39% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?